Parkavi Kalaiselvan

ORCID: 0000-0002-7204-784X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bone Metabolism and Diseases
  • Phytochemical compounds biological activities
  • Dermatological and COVID-19 studies
  • Long-Term Effects of COVID-19
  • COVID-19 Clinical Research Studies
  • Bone health and treatments
  • Plant-derived Lignans Synthesis and Bioactivity
  • Genomics, phytochemicals, and oxidative stress
  • T-cell and Retrovirus Studies
  • Phytochemicals and Antioxidant Activities
  • Cell Adhesion Molecules Research
  • Cutaneous lymphoproliferative disorders research
  • Protease and Inhibitor Mechanisms
  • S100 Proteins and Annexins

Texas Tech University Health Sciences Center
2023

Texas Tech University
2023

Chettinad Health City
2020-2021

Background: Breast cancer (BC) produces bone resorptive cytokines and growth factors which accelerate the development of osteoclasts (OCs), leading to osteolytic metastases. In Long-term Odanacatib Fracture Trial (LOFT), skeletal-metastasized breast subjects who received odanacatib (ODN) had a delayed tumour progression skeletal burden as result anti-resorptive effects through inhibition cathepsin K (CTSK). this study, we explored effect ODN, CTSK inhibitor, on paracrine pro-osteoclast...

10.2174/1874467214666210211162118 article EN Current Molecular Pharmacology 2021-02-12

Background: Hesperetin is a natural compound known for its cholesterol-lowering effect and wide range of pharmacological activities. Objectives: Investigating the potential anticancer activities in malignant hematolymphoid cell lines HuT78 MJ, derived from patients with Cutaneous T-Cell Lymphomas (CTCL). Methods: The cytotoxic on two different CTCL lines, was assessed by MTS-based colorimetric assay. Apoptosis, cycle, ROS (Reactive Oxygen Species) molecular analysis were performed using...

10.2174/1871521409666200324110031 article EN Anti-Cancer Agents in Medicinal Chemistry 2020-03-24
Coming Soon ...